Morgan Stanley’s Aceragen Inc ACGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,860
| Closed | -$7.92K | – | 7783 |
|
|
2023
Q2 | $7.92K | Buy |
4,860
+5
| +0.1% | +$9 | ﹤0.01% | 6887 |
|
|
2023
Q1 | $11.1K | Sell |
4,855
-1,350
| -22% | -$7.06K | ﹤0.01% | 6848 |
|
|
2022
Q4 | $36.9K | Buy |
6,205
+815
| +15% | +$4.89K | ﹤0.01% | 6417 |
|
|
2022
Q3 | $34K | Buy |
5,390
+447
| +9% | +$3.37K | ﹤0.01% | 6577 |
|
|
2022
Q2 | $39K | Sell |
4,943
-2,539
| -34% | -$21.6K | ﹤0.01% | 6721 |
|
|
2022
Q1 | $64K | Buy |
7,482
+52
| +0.7% | +$470 | ﹤0.01% | 6581 |
|
|
2021
Q4 | $72K | Sell |
7,430
-241
| -3% | -$3.23K | ﹤0.01% | 6626 |
|
|
2021
Q3 | $133K | Buy |
7,671
+789
| +11% | +$14.2K | ﹤0.01% | 6209 |
|
|
2021
Q2 | $139K | Sell |
6,882
-91
| -1% | -$1.83K | ﹤0.01% | 6193 |
|
|
2021
Q1 | $154K | Buy |
6,973
+6,432
| +1,189% | +$482K | ﹤0.01% | 5804 |
|
|
2020
Q4 | $34K | Buy |
541
+88
| +19% | +$5.05K | ﹤0.01% | 6276 |
|
|
2020
Q3 | $17K | Buy |
453
+137
| +43% | +$4.87K | ﹤0.01% | 6122 |
|
|
2020
Q2 | $10K | Hold |
316
| – | – | ﹤0.01% | 6166 |
|
|
2020
Q1 | $7K | Buy |
316
+96
| +44% | +$2.61K | ﹤0.01% | 6126 |
|
|
2019
Q4 | $7K | Sell |
220
-63
| -22% | -$2.34K | ﹤0.01% | 6355 |
|
|
2019
Q3 | $14K | Sell |
283
-392
| -58% | -$17.2K | ﹤0.01% | 6116 |
|
|
2019
Q2 | $31K | Buy |
675
+378
| +127% | +$17.9K | ﹤0.01% | 5794 |
|
|
2019
Q1 | $13K | Sell |
297
-1,545
| -84% | -$74.7K | ﹤0.01% | 6127 |
|
|
2018
Q4 | $87K | Sell |
1,842
-78
| -4% | -$8.97K | ﹤0.01% | 5601 |
|
|
2018
Q3 | $290K | Sell |
1,920
-1,206
| -39% | -$172K | ﹤0.01% | 5281 |
|
|
2018
Q2 | $561K | Buy |
3,126
+744
| +31% | +$174K | ﹤0.01% | 5020 |
|
|
2018
Q1 | $596K | Sell |
2,382
-242
| -9% | -$66.4K | ﹤0.01% | 4897 |
|
|
2017
Q4 | $753K | Buy |
2,624
+1,477
| +129% | +$422K | ﹤0.01% | 4738 |
|
|
2017
Q3 | $348K | Sell |
1,147
-186
| -14% | -$48.6K | ﹤0.01% | 5082 |
|
|
2017
Q2 | $311K | Sell |
1,333
-982
| -42% | -$257K | ﹤0.01% | 5090 |
|
|
2017
Q1 | $777K | Sell |
2,315
-13
| -0.6% | -$3.13K | ﹤0.01% | 4567 |
|
|
2016
Q4 | $475K | Buy |
2,328
+1,930
| +485% | +$460K | ﹤0.01% | 4967 |
|
|
2016
Q3 | $137K | Sell |
398
-89
| -18% | -$23.5K | ﹤0.01% | 5177 |
|
|
2016
Q2 | $101K | Buy |
487
+199
| +69% | +$43.9K | ﹤0.01% | 5234 |
|
|
2016
Q1 | $77K | Buy |
288
+62
| +27% | +$16.6K | ﹤0.01% | 5433 |
|
|
2015
Q4 | $95K | Sell |
226
-50
| -18% | -$22.4K | ﹤0.01% | 5435 |
|
|
2015
Q3 | $126K | Sell |
276
-369
| -57% | -$163K | ﹤0.01% | 5311 |
|
|
2015
Q2 | $325K | Buy |
645
+445
| +223% | +$204K | ﹤0.01% | 4973 |
|
|
2015
Q1 | $101K | Sell |
200
-9
| -4% | -$5.49K | ﹤0.01% | 5522 |
|
|
2014
Q4 | $125K | Sell |
209
-579
| -73% | -$232K | ﹤0.01% | 5458 |
|
|
2014
Q3 | $246K | Buy |
788
+320
| +68% | +$115K | ﹤0.01% | 5030 |
|
|
2014
Q2 | $184K | Buy |
468
+433
| +1,237% | +$179K | ﹤0.01% | 5207 |
|
|
2014
Q1 | $19K | Sell |
35
-2,377
| -99% | -$1.63M | ﹤0.01% | 5978 |
|
|
2013
Q4 | $1.52M | Buy |
+2,412
| New | +$805K | ﹤0.01% | 3593 |
|
Other funds holding ACGN
Morgan Stanley's ACGN Position: Q3 2023 in Review
Morgan Stanley sold out of Aceragen Inc (ACGN) in Q3 2023, closing a stake of 4,860 shares — an estimated $7.92K sold.
Morgan Stanley first reported a position in ACGN in Q4 2013 and held it in 39 quarters. The position peaked at $1.52M in Q4 2013. 3 funds tracked by Wall St. Rank hold ACGN as of Q3 2023.
- Morgan Stanley reported no remaining Aceragen Inc position as of Q3 2023 after selling out during the quarter.
- Morgan Stanley sold 4,860 Aceragen Inc shares in Q3 2023, an estimated $7.92K.
- Morgan Stanley first reported a position in Aceragen Inc in Q4 2013 and held it in 39 quarters.
- Morgan Stanley's Aceragen Inc position peaked at $1.52M in Q4 2013.
- 3 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2023.
Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.